Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk

Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET

(2022) Cécile Tissot et al.   EBioMedicine

Cardiovascular disease and the risk of dementia: a survival analysis using administrative data from Manitoba

(2022) Luc Clair et al.   CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE

Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice

(2022) Sid E. O'Bryant et al.   Alzheimers & Dementia

A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

(2022) Stephen A. Williams et al.   Science Translational Medicine

Assessment of variability in the plasma 7k SomaScan proteomics assay

(2022) Julián Candia et al.   Scientific Reports

Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study

(2022) Mary R Rooney et al.   CLINICAL CHEMISTRY

Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers

(2022) Zhongsheng Peng et al.   NEUROBIOLOGY OF AGING

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease

(2021) Alexis Moscoso et al.   JAMA Neurology

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

(2021) Pratishtha Chatterjee et al.   Translational Psychiatry

Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association

(2021) Salim S. Virani et al.   CIRCULATION

The ARIC (Atherosclerosis Risk In Communities) Study

(2021) Jacqueline D. Wright et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Default mode network connectivity and cognition in the aging brain: the effects of age, sex, and APOE genotype.

(2021) Andrea T. Shafer et al.   NEUROBIOLOGY OF AGING

Association between chronic kidney disease and Alzheimer’s disease: an update

(2020) Chun-Yun Zhang et al.   METABOLIC BRAIN DISEASE

Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis

(2020) James D. Doecke et al.   NEUROLOGY

Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease

(2020) Niklas Mattsson-Carlgren et al.   Science Advances

Synergy between amyloid-β and tau in Alzheimer’s disease

(2020) Marc Aurel Busche et al.   NATURE NEUROSCIENCE

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop

(2020) Berislav V. Zlokovic et al.   Alzheimers & Dementia

High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

(2019) Suzanne E. Schindler et al.   NEUROLOGY

Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

(2019) Sebastian Palmqvist et al.   JAMA Neurology

Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia

(2019) Keenan A. Walker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life

(2019) Christopher A. Lane et al.   JAMA Neurology

Plasma protein patterns as comprehensive indicators of health

(2019) Stephen A. Williams et al.   NATURE MEDICINE

Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases

(2018) Guray Erus et al.   NEUROIMAGE

Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition

(2017) Rebecca F. Gottesman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Assessment of Variability in the SOMAscan Assay

(2017) Julián Candia et al.   Scientific Reports

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

(2016) Ramon Casanova et al.   Alzheimers & Dementia

Mediation Analysis: A Practitioner's Guide

(2016) Tyler J. VanderWeele   Annual Review of Public Health

Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease

(2016) Peter Ganz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Plasma β-amyloid in Alzheimer’s disease and vascular disease

(2016) Shorena Janelidze et al.   Scientific Reports

Heart failure and Alzheimer′s disease

(2014) P. Cermakova et al.   JOURNAL OF INTERNAL MEDICINE

Amyloid-β and Tau

(2014) George S. Bloom   JAMA Neurology

Assessing the "Physical Cliff": Detailed Quantification of Age-Related Differences in Daily Patterns of Physical Activity

(2013) J. A. Schrack et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The Baltimore Longitudinal Study of Aging (BLSA): A 50-Year-Long Journey and Plans for the Future

(2011) L. Ferrucci   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery

(2011) Larry Gold et al.   PLoS One

Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification

(2010) Christos Davatzikos et al.   NEUROBIOLOGY OF AGING

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

(2009) C. Davatzikos et al.   BRAIN

Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

(2007) Yong Fan et al.   NEUROIMAGE